NCT00436293View on ClinicalTrials.gov

Taxotere + Cisplatin in Nasopharyngeal Carcinoma

PHASE2CompletedINTERVENTIONAL

Enrollment

61

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Nasopharyngeal Neoplasms

Interventions

DRUG

Docetaxel

75 mg/m²

DRUG

Cisplatin

75 mg/m²

Trial Locations (1)

Unknown

Sanofi-Aventis, Hong Kong

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY